No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 0 | 0 | 0 | 0 | 0 | 0 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | -0 | -0 | 2 | -1 | 1 | 1 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Innovative-RFK S.p.A. functions as a private equity and venture capital firm, primarily focused on injecting capital into small and medium-sized enterprises (SMEs). The firm supports companies across their developmental spectrum, from initial start-up phases to emerging and established growth. Beyond direct company investments, it also allocates capital to other private equity funds through a fund-of-funds strategy. Its investment preferences span sectors such as biomedical systems, microcredit solutions for SMEs, information technology, the broader high-tech industry, and innovative solutions applicable across various industries. Geographically, Innovative-RFK predominantly targets companies based in Italy. The firm typically commits up to €3 million (approximately $3.54 million) to companies that demonstrate an enterprise value and sales revenue of up to €50 million (around $58.96 million), with an EBITDA reaching up to €5 million (roughly $5.90 million). These investments are funded directly from its own proprietary capital. Innovative-RFK is flexible in its ownership approach, acquiring either minority or majority equity stakes in its portfolio companies. An Initial Public Offering (IPO) serves as its preferred exit strategy, typically targeted within an ambitious 18 to 24-month timeframe. Innovative-RFK S.p.A. was established in 2017 and is headquartered in Milan, Italy.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Innovative-RFK S.p.A. (MLIRF.PA)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Innovative-RFK S.p.A. functions as a private equity and venture capital firm, primarily focused on injecting capital into small and medium-sized enterprises (SMEs). The firm supports companies across their developmental spectrum, from initial start-up phases to emerging and established growth. Beyond direct company investments, it also allocates capital to other private equity funds through a fund-of-funds strategy. Its investment preferences span sectors such as biomedical systems, microcredit solutions for SMEs, information technology, the broader high-tech industry, and innovative solutions applicable across various industries. Geographically, Innovative-RFK predominantly targets companies based in Italy. The firm typically commits up to €3 million (approximately $3.54 million) to companies that demonstrate an enterprise value and sales revenue of up to €50 million (around $58.96 million), with an EBITDA reaching up to €5 million (roughly $5.90 million). These investments are funded directly from its own proprietary capital. Innovative-RFK is flexible in its ownership approach, acquiring either minority or majority equity stakes in its portfolio companies. An Initial Public Offering (IPO) serves as its preferred exit strategy, typically targeted within an ambitious 18 to 24-month timeframe. Innovative-RFK S.p.A. was established in 2017 and is headquartered in Milan, Italy.
